Press release
Peptide Therapeutics Market Report 2023: By Key Players, Trends, Size, Share and Forecast 2023-2029
The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides have gained a wide range of applications in medicine and biotechnology. In the last five years (2015-2019), the US Food Drug Administration (FDA) has authorized a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules, which account for 7% of the total number of drugs. The primary factor that drives the peptide therapeutics market growth includes the potent and specific, yet safe, mode of action of peptides.Besides the increased prevalence of diseases such as cancer also drives the global peptide therapeutics industry growth during the forecast period. Increased rate of mortality due to cancer has led to an increase in emphasis on the advancements of the drugs and products to combat the situation, which fuels the growth for the global peptide therapeutics market over the forecast period.
A full report of Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/peptide-therapeutics-market
Based on the route of the delivery segment of the market, oral held the key share in the market. Oral delivery is the preferred route of drug administration, as the majority of patients see it as the most convenient way to take their drugs. Drugs taken by the oral route have the highest level of patient compliance due to the ease and simplicity of taking medications. Despite a large number of protein therapeutics being discovered each year, oral delivery continues to be a barrier. As a whole, protein and peptide drugs have low bioavailability when administered orally due to problematic barriers including gastrointestinal proteases, the epithelial barrier, and efflux pumps.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/peptide-therapeutics-market
Further, the presence of the key players that provides suitable and proper drugs also drives the growth of the peptide therapeutics market during the forecast period. Players such as Amgen Inc., Eli Lilly and Co., Pfizer, Inc., Bristol-Myer Squibb Co., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., and others are some of the key players contributing to the growth of the market.
Global Peptide Therapeutics Market - Segmentation
By Route of Administration
Oral
Parenteral
By Application
Cancer
Gastrointestinal Disorders
Central Nervous System Disorders
Respiratory Disorders
Others
Global Peptide Therapeutics Market - Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
Company Profiles
Amgen, Inc.
AstraZeneca Plc
Bachem Holding AG
Bristol-Myers Squibb Co.
CordenPharma InternationalGmbH
Eli Lilly and Co.
Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Lonza Group AG
Merck & Co. Inc.
Novartis International AG
Novo Nordisk A/S
Pfizer, Inc.
PolyPeptide Group
Visit more report at
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/%ec%9e%91%eb%ac%bc-%eb%b3%b4%ed%98%b8-%ec%8b%9c%ec%9e%a5-%eb%b3%b4%ea%b3%a0%ec%84%9c-2023-%ec%a3%bc%ec%9a%94-%ec%97%85%ec%b2%b4%eb%b3%84-%eb%8f%99%ed%96%a5-%ea%b7%9c%eb%aa%a8-%ec%a0%90%ec%9c%a0/47904/
https://www.asiatimeskorea.com/press-release/phosphoinositide-kinase-%ec%96%b5%ec%a0%9c%ec%a0%9c-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%eb%af%b8%eb%9e%98-%ec%a0%84%eb%a7%9d-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ec%98%88%ec%b8%a1-2023-2029/412374/
https://monblogapple.com/2023/03/25/rapport-sur-le-marche-des-liants-de-phosphate-2023-par-acteurs-cles-tendances-taille-part-et-previsions-2023-2029/
https://revistaeconomiasocial.com/2023/03/25/tratamiento-de-fenilcetonuria-cuota-de-mercado-2023-tendencias-jugadores-clave-analisis-y-pronostico-2023-2029/
https://sportmsr.com/%d8%aa%d9%82%d8%b1%d9%8a%d8%b1-%d8%b3%d9%88%d9%82-%d8%a3%d8%ac%d9%87%d8%b2%d8%a9-%d8%a7%d9%84%d8%aa%d9%86%d9%81%d8%b3-%d8%a7%d9%84%d8%b5%d9%86%d8%a7%d8%b9%d9%8a-%d9%84%d8%b9%d8%a7%d9%85-2022-%d8%ad/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Report 2023: By Key Players, Trends, Size, Share and Forecast 2023-2029 here
News-ID: 2989808 • Views: …
More Releases from Orion Market Research

Antivirus Software Market Size Unlocking New Opportunities for Success
The global antivirus software market was about USD 4.0-4.7 billion in 2023, and is expected to grow to approximately USD 11.0 billion by 2033, with a CAGR of around 8.5% over the 2024-2033 period.
Antivirus Software Market Overview
The antivirus software market is a key segment of cybersecurity, focused on protecting devices and networks from malware, ransomware, viruses, spyware, and other malicious software. Growth is being driven by the increasing frequency and…

Aircraft Ignition System Market Analysis Current Landscape and Future Outlook
The global aircraft ignition system market is expected to reach USD 819.32 million by 2033, growing at a CAGR of 6.35% from 2024 to 2033.
Aircraft Ignition System Market Overview
The aircraft ignition system market is a specialized segment of aerospace & defense focused on components that initiate and maintain combustion in aircraft engines-spark plugs, ignition leads, igniters, exciters, etc. Innovations are steering the market away from traditional magneto systems toward more…

EConsent in Healthcare Market Set to Witness Significant Growth by 2033 | Veeva …
The EConsent in Healthcare Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.8 billion by 2033, growing at a CAGR of 12.5% from 2025 to 2033.
EConsent in Healthcare Market Overview
The EConsent in Healthcare Market is witnessing strong growth as healthcare providers increasingly adopt digital consent solutions to streamline patient onboarding, clinical trials, and data-sharing processes. The shift toward electronic health records (EHRs),…

Property Management Software (PMS) Market Set to Witness Significant Growth by 2 …
The Property Management Software (PMS) Market was valued at USD 4.2 billion in 2024 and is projected to reach USD 10.1 billion by 2033, growing at a CAGR of 10.1% from 2025 to 2033.
Property Management Software (PMS) Market Overview
The Property Management Software Market is experiencing significant growth as real estate, hospitality, and facility management sectors increasingly adopt digital solutions to streamline operations. PMS enables efficient management of property listings,…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…